ConductScience.org, home

Paper402104

In vitro activity of netilmicin, gentamicin, and amikacin.

Kantor RJ and 1 other. Antimicrob Agents Chemother, 1977. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro activity of netilmicin, gentamicin, and amikacin. Papers, record 402104. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/402104

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro activity of netilmicin, gentamicin, and amikacin.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1977
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.49
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kantor RJR J
2Norden CWC W

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoglycosidesMajor topic
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
Amikacin
Drug Resistance, Microbial
Enterobacteriaceae
Gentamicins
Pseudomonas aeruginosa
Species Specificity
Staphylococcus aureus

Source PubMed

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1825,025Comparative in vitro activity of Sch 20656, netilmicin, gentamicin, and tobramycin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/825025PubMed
2825,021In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/825021PubMed
3817,661Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/817661PubMed
44,208,506Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4208506PubMed
54,793,881Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4793881PubMed
64,275,226Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4275226PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
35,203,796XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin?Antibiotics (Basel)2022https://conductscience.org/library/papers/35203796PubMed
7,049,074Assay of netilmicin, using enzyme immunoassay for gentamicin.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7049074PubMed
2,689,137Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1989https://conductscience.org/library/papers/2689137PubMed
426,506Netilmicin in gram-negative bacterial infections.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/426506PubMed
363,053Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/363053PubMed
354,518Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/354518PubMed
348,093Outbreak of multiply drug-resistant Proteus mirabilis originating in a surgical intensive care unit: in vitro susceptibility pattern.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/348093PubMed
348,092Netilmicin: clinical efficacy, tolerance, and toxicity.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/348092PubMed
335,960Clinical and bacteriological evaluation of netilmicin in gram-negative infections.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/335960PubMed
263,882Comparative distribution of gentamicin, tobramycin, sisomicin, netilmicin, and amikacin in interstitial fluid in rabbits.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/263882PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/402104

GET https://conductscience.org/api/papers/v1/402104/authors